{"id":2434,"date":"2025-01-14T18:31:17","date_gmt":"2025-01-14T15:31:17","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=2434"},"modified":"2025-01-14T18:31:19","modified_gmt":"2025-01-14T15:31:19","slug":"immunoforge-receives-fda-ind-approval-for-phase-2-clinical-trial-of-pemziviptadil-for-dmd-cardiomyopathy","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/pt\/immunoforge-receives-fda-ind-approval-for-phase-2-clinical-trial-of-pemziviptadil-for-dmd-cardiomyopathy\/","title":{"rendered":"ImmunoForge recebe aprova\u00e7\u00e3o FDA IND para ensaio cl\u00ednico de fase 2 de &#039;Pemziviptadil&#039; para cardiomiopatia DMD"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Um medicamento para cardiomiopatia DMD, o pemziviptadil \u00e9 usado uma vez por semana e \u00e9 baseado na Plataforma ELP (Plataforma de Polipept\u00eddeo Semelhante \u00e0 Elastina) da ImmunForge, uma plataforma farmacol\u00f3gica de a\u00e7\u00e3o prolongada. Para melhorar a fun\u00e7\u00e3o card\u00edaca, o pemziviptadil, um pept\u00eddeo intestinal vasoativo (VIP), atua preferencialmente no receptor 2 do pept\u00eddeo intestinal vasoativo (VPAC2) para promover a contra\u00e7\u00e3o e o relaxamento do cora\u00e7\u00e3o.<\/p>","protected":false},"excerpt":{"rendered":"<p>Um medicamento para cardiomiopatia DMD, o pemziviptadil \u00e9 usado uma vez por semana e \u00e9 baseado na Plataforma ELP (Plataforma de Polipept\u00eddeo Semelhante \u00e0 Elastina) da ImmunForge, uma plataforma farmacol\u00f3gica de a\u00e7\u00e3o prolongada. Para melhorar a fun\u00e7\u00e3o card\u00edaca, o pemziviptadil, um pept\u00eddeo intestinal vasoativo (VIP), atua preferencialmente no receptor 2 do pept\u00eddeo intestinal vasoativo (VPAC2) para promover a contra\u00e7\u00e3o e o relaxamento do cora\u00e7\u00e3o.<\/p>","protected":false},"author":1,"featured_media":2436,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27],"tags":[66,156,157,159,158],"class_list":["post-2434","post","type-post","status-publish","format-standard","has-post-thumbnail","category-research","tag-duchenne-muscular-dystrophy","tag-immunoforge","tag-pemziviptadil","tag-pf1804","tag-south-korea"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/posts\/2434","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/comments?post=2434"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/posts\/2434\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/media\/2436"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/media?parent=2434"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/categories?post=2434"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/pt\/wp-json\/wp\/v2\/tags?post=2434"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}